<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03283956</url>
  </required_header>
  <id_info>
    <org_study_id>201708028RINC</org_study_id>
    <nct_id>NCT03283956</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan</brief_title>
  <acronym>SERENADE-T</acronym>
  <official_title>Safety and Efficacy of dRug-ElutiNg beADs Trans-arterial chemoEmbolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate efficacy and safety profile of DC bead® TACE in patients with hepatocellular&#xD;
      carcinoma in Taiwan.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate efficacy and safety profile of DC bead TACE in patients with hepatocellular&#xD;
      carcinoma in Taiwan.&#xD;
&#xD;
      This is a multi-center, retrospective, single arm study to explore safety and efficacy of DC&#xD;
      bead TACE in hepatocellular carcinoma (HCC) in Taiwan&#xD;
&#xD;
      Retrospective analysis of medical records of all patients who underwent DC Bead TACE at&#xD;
      National Taiwan University Hospital, National Cheng Kung University Hospital, and Taichung&#xD;
      Veterans General Hospital from 2010-2017/7.&#xD;
&#xD;
      All statistical data were analyzed with SPSS software (SPSS, IBM North America, New York, NY,&#xD;
      USA). Demographic and baseline lab data are presented by using descriptive statistics&#xD;
      Student's t-test. Survival analysis will includes all patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">September 13, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of the DC bead TACE</measure>
    <time_frame>One year.</time_frame>
    <description>Safety of the DC bead TACE is evaluated based on the incidence of Grade 3 and Grade 4 toxicities up to 8 weeks following the procedure according to National Cancer Institute's Common Terminology Criteria for adverse events (CTCAE Version 4.03).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tumor response</measure>
    <time_frame>One year.</time_frame>
    <description>Tumor response is assessed on triphase CT or contrast-enhanced MR study according to modified Response Evaluation Criteria in Solid Tumors (mRECIST) criteria.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Hepatocellular Carcinoma Non-resectable</condition>
  <condition>Chemoembolization, Therapeutic</condition>
  <arm_group>
    <arm_group_label>Patient records</arm_group_label>
    <description>Medical records of all patients who underwent DC bead TACE.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient records</intervention_name>
    <description>Retrospective analysis of medical records of all patients who underwent DC Bead TACE at National Taiwan University Hospital, National Cheng Kung University Hospital, and Taichung Veterans General Hospital from 2010-2017/7</description>
    <arm_group_label>Patient records</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Medical records of all patients who underwent DC bead TACE at National Taiwan University&#xD;
        Hospital, National Cheng Kung University Hospital, and Taichung Veterans General Hospital&#xD;
        from 2010-2017/7&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with a diagnosis of HCC, according to the AASLD diagnosis criteria for HCC.&#xD;
&#xD;
          -  Patient received DC bead TACE.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with current any other cancer except non-melanomatous skin cancer.&#xD;
&#xD;
          -  Infiltrative HCC&#xD;
&#xD;
          -  Patients received ≥2 consecutive sessions of TACE (≥2 TACE at the same admission, no&#xD;
             matter it is cTACE or DC bead TACE)&#xD;
&#xD;
          -  Patients received DC bead TACE and simultaneously received other therapy, such as&#xD;
             radiotherapy, sorafenib etc.&#xD;
&#xD;
          -  Presence of collateral vessel pathways potentially endangering normal territories&#xD;
             during embolization.&#xD;
&#xD;
          -  Presence of arteries supplying the lesion not large enough to accept DC Bead®&#xD;
             microspheres.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chien-Hung Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chien-Hung Chen, MD</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>65923</phone_ext>
    <email>chenhcc@ntuh.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Chien-Hung Chen, MD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>65923</phone_ext>
      <email>chenhcc@ntuh.gov.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <study_first_submitted>September 13, 2017</study_first_submitted>
  <study_first_submitted_qc>September 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 15, 2017</study_first_posted>
  <last_update_submitted>September 13, 2017</last_update_submitted>
  <last_update_submitted_qc>September 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

